Camostat Mesylate in COVID-19 Outpatients
NCT04353284
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
70
Enrollment
OTHER
Sponsor class
Conditions
COVID-19
Interventions
DRUG:
Camostat Mesilate
OTHER:
Placebo
Sponsor
Yale University